Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review

@article{Robin2016SafetyOC,
  title={Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review},
  author={Tyler P. Robin and Gregory N Gan and Moses M Tam and David Westerly and Nadeem Riaz and Sana D. Karam and Nancy Y. Lee and David Raben},
  journal={Head \& Neck},
  year={2016},
  volume={38}
}
Previous groups have shown contralateral submandibular gland sparing to improve xerostomia with safe outcomes, but primarily in early‐stage disease. In this study, we present a large cohort of patients with locally advanced head and neck cancer that underwent contralateral submandibular gland‐sparing radiotherapy, to demonstrate feasibility and safety specifically in patients with locally advanced disease. 
14 Citations

Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients

Contralateral submandibular gland transfer before radiotherapy was shown to reduce xerostomia compared to pilocarpine, and a modification of this surgery preserving the ipsilateral facial artery and vein was evaluated to simplify the SMG‐T.

Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base

The overall survival (OS) benefit of concurrent chemoradiotherapy (CRT) for head and neck squamous cell carcinoma patients older than 70 years is debated. This study examines the outcomes of elderly

Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.

  • Da-wei ZhaoW. Fan Lin Ma
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2022

Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.

  • W. FanFeng Teng J. Guan
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2021

Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life.

Regional Radiation Therapy for Oropharyngeal Cancer in the HPV Era.

  • M. TamK. Hu
  • Medicine
    Seminars in radiation oncology
  • 2019

Submandibular function recovery after IMRT in head and neck cancer: A prospective dose modelling study.

  • V. MurthyS. Lewis J. Agarwal
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2018

References

SHOWING 1-10 OF 27 REFERENCES

Submandibular salivary gland transfer for the prevention of radiation‐induced xerostomia in patients with nasopharyngeal carcinoma: 5‐Year outcomes

The value of the submandibular salivary gland transfer procedure in prevention of radiation‐induced xerostomia in patients with nasopharyngeal carcinoma (NPC) is investigated.

Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: Sites of locoregional relapse and survival

In selected head and neck cancer patients who are estimated to have a low risk of cancer recurrence at the nodal levels I–II and who are treated with SMG-sparing IMRT the risk ofcancer recurrence in the vicinity of the spared salivary glands is low.

Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.

Sparing the contralateral submandibular gland in oropharyngeal cancer patients: a planning study.

Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control

Over 92% of LR failures occurred “in-field” within the high dose region when using intensity-modulated radiotherapy with whole salivary gland-sparing strategy, and sparing SMG and OC in addition to PG thus appears a safe strategy.

Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.

Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia.

The SJP prevented xerostomia in 83% of the study patients, and the approach appears to be oncologically sound and safe.

Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts

The records of 2,044 patients with previously untreated squamous cell carcinomas of the head and neck were reviewed in order to define the incidence and topographical distribution of lymph node